Multiple Sclerosis (MS) is a demyelinating disease of the human central nervous system
having an unconfirmed pathoetiology. Although animal models are used to mimic the …

Multiple sclerosis (MS) is a neuroinflammatory disorder characterized by autoimmune-
mediated inflammatory lesions in CNS leading to myelin damage and axonal loss. MS is a …

Multiple sclerosis (MS) is a chronic inflammatory demyelinating and neurodegenerative
disease of the central nervous system (CNS). The cause of MS is unknown, with no effective …

Multiple sclerosis (MS) is the inflammatory demyelinating and neurodegenerative disease of
the central nervous system (CNS) that affects approximately 2.8 million people worldwide. In …

Multiple sclerosis, which is the most common cause of chronic neurological disability in
young adults, is an inflammatory, demyelinating, and neurodegenerative disease of the …

Multiple sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous
system (CNS) resulting in demyelination and axonal loss in the brain and spinal cord. The …

Multiple sclerosis is a disabling inflammatory and neurodegenerative disorder that
predominantly affects young adults. There is a great need for biomarkers, which could …

Currently, there is no single test for multiple sclerosis (MS). Diagnosis is confirmed through
clinical evaluation, abnormalities revealed by magnetic resonance imaging (MRI), and …

Objective Here, we aimed to identify protein biomarkers that could rapidly and accurately
diagnose multiple sclerosis (MS) using a highly sensitive proteomic immunoassay. Methods …

Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous
system (CNS) which can lead to severe disability. Several diseases can mimic the clinical …